… pulmonary exacerbations in CF. In this review, the efficacy and safety of the currently available
inhaled antibiotics … Moreover, the effects of long-term inhaled antibiotic therapy for chronic …

… Additionally, inhaled liposomal amikacin and murepavadin are … inhaled antibiotics will
be summarized. Combination therapy and the strategies to select an optimal inhaled antibiotic …

… inhaled antibiotics for the treatment of pulmonary exacerbations in people with cystic
fibrosis… trial of inhaled antibiotics for the management of pulmonary exacerbations (NCT03066453). …

… The first report of inhaled antibiotic use in CF appeared in the … use of inhaled antibiotics in
the CF population. The development of inhaled antibiotics has primarily focused on antibiotics …

… antibiotic therapy for non-cystic fibrosis bronchiectasis (NCFB) has yet to be determined.
A meta-analysis was conducted to evaluate the efficacy and safety of inhaled antibiotics in …

… pulmonary infections in people with CF. This article reviews the role of inhaled antibiotics
in … fibrosis patients who receive cystic fibrosis transmembrane conductance regulator (CFTR) …

… Further, we speculated that adherence to inhaled antibiotics was challenged by the … of
inhaled antibiotic use, this study describes the use of different types of inhaled antibiotics against …

… Recently, inhaled antibiotics have become a precious tool in the management of lung …
at the site of infection which allows the drug inhaled dose to be reduced compared to that …

… This study is the first to compare safety and effectiveness of inhaled antibiotics in non-hospitalized
adults with NCFB, depending on the aerosol generating devices. Both DPI and SVN …

… on aerosol therapy during the escalation of care using a bench model of adult CF. Droplet
size analysis of selected antibiotics was completed in tandem with the delivered aerosol dose (…